RIZZI, Michele
 Distribuzione geografica
Continente #
NA - Nord America 498
EU - Europa 89
AS - Asia 87
Totale 674
Nazione #
US - Stati Uniti d'America 497
CN - Cina 47
SG - Singapore 27
UA - Ucraina 23
GB - Regno Unito 20
DE - Germania 16
TR - Turchia 13
SE - Svezia 9
IT - Italia 8
FI - Finlandia 7
BE - Belgio 3
AT - Austria 1
CA - Canada 1
DK - Danimarca 1
FR - Francia 1
Totale 674
Città #
Fairfield 69
Woodbridge 62
Houston 49
Chandler 43
Ashburn 38
Jacksonville 30
Seattle 24
Cambridge 21
Ann Arbor 20
Singapore 18
Wilmington 18
Santa Clara 15
San Diego 13
Beijing 12
Nanjing 11
New York 8
Boardman 7
Izmir 7
Princeton 7
Shanghai 6
Addison 5
Los Angeles 5
Bremen 3
Brussels 3
Shenyang 3
Changsha 2
Falls Church 2
Jiaxing 2
Jinan 2
Nanchang 2
Orange 2
San Mateo 2
Tianjin 2
Washington 2
Acton 1
Auburn Hills 1
Chicago 1
Frankfurt am Main 1
Fuzhou 1
Guangdong 1
Helsinki 1
Kunming 1
London 1
Miami 1
Ottawa 1
Philadelphia 1
Rome 1
Simi Valley 1
Verona 1
Vienna 1
Wakefield 1
Wuhan 1
Totale 533
Nome #
Novel A-ring and B-ring modified combretastatin A-4 (CA-4) analogues endowed with interesting cytotoxic activity 128
Novel terphenyls and 3,5-diaryl isoxazole derivatives endowed with growth supporting and antiapoptotic properties 122
Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer 115
Novel combretastatin analogues endowed with antitumor activity 107
The antitumor activities of curcumin and of its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 breast cancer cell line: Analysis of the possible molecular basis 105
Antitumor effects of curcumin and structurally β-diketone modified analogs on multidrug resistant cancer cells 102
Totale 679
Categoria #
all - tutte 3.273
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.273


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202092 0 0 0 0 11 18 14 13 15 11 8 2
2020/202167 6 5 3 8 2 9 2 11 1 9 7 4
2021/202280 3 6 11 2 3 2 6 2 4 4 7 30
2022/202392 6 6 5 12 16 13 0 11 16 2 5 0
2023/202451 1 5 2 3 6 16 0 3 2 1 0 12
2024/202549 2 4 13 11 19 0 0 0 0 0 0 0
Totale 679